Ontology type: schema:ScholarlyArticle Open Access: True
2013-09
AUTHORSDana E. Rathkopf, Joel Picus, Arif Hussain, Susan Ellard, Kim Nguyen Chi, Thomas Nydam, Erin Allen-Freda, Kaushal Kishor Mishra, Maria Grazia Porro, Howard I. Scher, George Wilding
ABSTRACTPURPOSE: Panobinostat, a pan-deacetylase inhibitor, increases acetylation of proteins associated with growth and survival of malignant cells. This phase 2 study evaluated the efficacy of intravenous (IV) panobinostat in patients with castration-resistant prostate cancer (CRPC) who had previously received chemotherapy. The primary end point was 24-week progression-free survival. Secondary end points included safety, tolerability, and the proportion of patients with a prostate-specific antigen (PSA) decline. METHODS: IV panobinostat (20 mg/m(2)) was administered to patients on days 1 and 8 of a 21-day cycle. Tumor response was assessed by imaging every 12 weeks (4 cycles) according to modified response evaluation criteria in solid tumors (Scher et al. in Clin Cancer Res 11:5223-5232, 23), and PSA response was defined as a 50 % decrease from baseline maintained for ≥4 weeks. Safety monitoring was routinely performed and included electrocardiogram monitoring. RESULTS: Of 35 enrolled patients, four (11.4 %) were alive without progression of disease at 24 weeks. PSA was evaluated in 34 (97.1 %) patients: five (14.3 %) patients demonstrated a decrease in PSA but none ≥50 %; one patient (2.9 %) had carcinoembryonic antigen as a marker of his prostate cancer, which declined by 43 %. Toxicities regardless of relationship to panobinostat included fatigue (62.9 %), thrombocytopenia (45.7 %), nausea (51.4 %), and decreased appetite (37.1 %). CONCLUSIONS: Despite promising preclinical data and scientific rationale, treatment with IV panobinostat did not show a sufficient level of clinical activity to pursue further investigation as a single agent in CRPC. More... »
PAGES537-544
http://scigraph.springernature.com/pub.10.1007/s00280-013-2224-8
DOIhttp://dx.doi.org/10.1007/s00280-013-2224-8
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1017758793
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/23820963
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged, 80 and over",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antineoplastic Agents",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Disease-Free Survival",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Histone Deacetylase Inhibitors",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Hydroxamic Acids",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Indoles",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Infusions, Intravenous",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Orchiectomy",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Prostate-Specific Antigen",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Prostatic Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Treatment Outcome",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Memorial Sloan Kettering Cancer Center",
"id": "https://www.grid.ac/institutes/grid.51462.34",
"name": [
"Memorial Sloan-Kettering Cancer Center, New York, NY, USA"
],
"type": "Organization"
},
"familyName": "Rathkopf",
"givenName": "Dana E.",
"id": "sg:person.01106075135.47",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106075135.47"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Washington University in St. Louis",
"id": "https://www.grid.ac/institutes/grid.4367.6",
"name": [
"Siteman Cancer Center, Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, MO, USA"
],
"type": "Organization"
},
"familyName": "Picus",
"givenName": "Joel",
"id": "sg:person.0752503711.41",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752503711.41"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Greenebaum Cancer Center, University of Maryland, Baltimore, MD, USA"
],
"type": "Organization"
},
"familyName": "Hussain",
"givenName": "Arif",
"id": "sg:person.01135457735.37",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135457735.37"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "BC Cancer Agency",
"id": "https://www.grid.ac/institutes/grid.248762.d",
"name": [
"British Columbia Cancer Agency, Kelowna, BC, Canada"
],
"type": "Organization"
},
"familyName": "Ellard",
"givenName": "Susan",
"id": "sg:person.01004224136.10",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004224136.10"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "BC Cancer Agency",
"id": "https://www.grid.ac/institutes/grid.248762.d",
"name": [
"British Columbia Cancer Agency, Vancouver, BC, Canada"
],
"type": "Organization"
},
"familyName": "Chi",
"givenName": "Kim Nguyen",
"id": "sg:person.01142252161.65",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142252161.65"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Novartis (United States)",
"id": "https://www.grid.ac/institutes/grid.418424.f",
"name": [
"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"
],
"type": "Organization"
},
"familyName": "Nydam",
"givenName": "Thomas",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Novartis (United States)",
"id": "https://www.grid.ac/institutes/grid.418424.f",
"name": [
"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"
],
"type": "Organization"
},
"familyName": "Allen-Freda",
"givenName": "Erin",
"id": "sg:person.012275634715.41",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012275634715.41"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Novartis (United States)",
"id": "https://www.grid.ac/institutes/grid.418424.f",
"name": [
"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"
],
"type": "Organization"
},
"familyName": "Mishra",
"givenName": "Kaushal Kishor",
"id": "sg:person.01116567352.06",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116567352.06"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Novartis (Switzerland)",
"id": "https://www.grid.ac/institutes/grid.419481.1",
"name": [
"Novartis Pharma AG, Basel, Switzerland"
],
"type": "Organization"
},
"familyName": "Porro",
"givenName": "Maria Grazia",
"id": "sg:person.0671136741.48",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671136741.48"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Memorial Sloan Kettering Cancer Center",
"id": "https://www.grid.ac/institutes/grid.51462.34",
"name": [
"Memorial Sloan-Kettering Cancer Center, New York, NY, USA"
],
"type": "Organization"
},
"familyName": "Scher",
"givenName": "Howard I.",
"id": "sg:person.01060421735.36",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060421735.36"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Wisconsin\u2013Madison",
"id": "https://www.grid.ac/institutes/grid.14003.36",
"name": [
"Paul P. Carbone Cancer Center, University of Wisconsin, Madison, WI, USA"
],
"type": "Organization"
},
"familyName": "Wilding",
"givenName": "George",
"id": "sg:person.016113722177.62",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016113722177.62"
],
"type": "Person"
}
],
"citation": [
{
"id": "https://doi.org/10.3390/ph3092751",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1000403597"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/emboj/19.4.662",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1001936972"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1128/mcb.23.23.8563-8575.2003",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1003600906"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.2217/fon.09.36",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1006149341"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/1078-0432.ccr-06-3093",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1006258831"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nrc2887",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1006993157",
"https://doi.org/10.1038/nrc2887"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2008.18.9159",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1008720167"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/0008-5472.can-07-2057",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1011079005"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3816/cgc.2005.n.015",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1012400722"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa1014618",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1018044872"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.onc.1208833",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019291778",
"https://doi.org/10.1038/sj.onc.1208833"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.onc.1208833",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019291778",
"https://doi.org/10.1038/sj.onc.1208833"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.onc.1208833",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019291778",
"https://doi.org/10.1038/sj.onc.1208833"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00280-010-1289-x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021855880",
"https://doi.org/10.1007/s00280-010-1289-x"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00280-010-1289-x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021855880",
"https://doi.org/10.1007/s00280-010-1289-x"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/1078-0432.ccr-05-0109",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1027547437"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/pros.20673",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1028656990"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.canlet.2009.02.019",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1028927359"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/cncr.24597",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1030320408"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/cncr.24597",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1030320408"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nature03672",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1030798307",
"https://doi.org/10.1038/nature03672"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nature03672",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1030798307",
"https://doi.org/10.1038/nature03672"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2007.12.4487",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031178629"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/jnci/92.3.205",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032301848"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/1078-0432.ccr-08-2787",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033328549"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1155/2011/580318",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033372709"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1074/jbc.m512719200",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034710442"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa1207506",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044642614"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1006/bbrc.2001.5639",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1047128510"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/0008-5472.can-08-2216",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1048751420"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/pros.21051",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1050109720"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/pros.21051",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1050109720"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.bjc.6604199",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1052387252",
"https://doi.org/10.1038/sj.bjc.6604199"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1038/aja.2009.81",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1056439625"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1038/aja.2009.81",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1056439625"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.4161/epi.3.6.7273",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1072302870"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.1999.17.11.3461",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1074545753"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1074708142",
"type": "CreativeWork"
}
],
"datePublished": "2013-09",
"datePublishedReg": "2013-09-01",
"description": "PURPOSE: Panobinostat, a pan-deacetylase inhibitor, increases acetylation of proteins associated with growth and survival of malignant cells. This phase 2 study evaluated the efficacy of intravenous (IV) panobinostat in patients with castration-resistant prostate cancer (CRPC) who had previously received chemotherapy. The primary end point was 24-week progression-free survival. Secondary end points included safety, tolerability, and the proportion of patients with a prostate-specific antigen (PSA) decline.\nMETHODS: IV panobinostat (20\u00a0mg/m(2)) was administered to patients on days 1 and 8 of a 21-day cycle. Tumor response was assessed by imaging every 12\u00a0weeks (4 cycles) according to modified response evaluation criteria in solid tumors (Scher et al. in Clin Cancer Res 11:5223-5232, 23), and PSA response was defined as a 50\u00a0% decrease from baseline maintained for \u22654\u00a0weeks. Safety monitoring was routinely performed and included electrocardiogram monitoring.\nRESULTS: Of 35 enrolled patients, four (11.4\u00a0%) were alive without progression of disease at 24\u00a0weeks. PSA was evaluated in 34 (97.1\u00a0%) patients: five (14.3\u00a0%) patients demonstrated a decrease in PSA but none \u226550\u00a0%; one patient (2.9\u00a0%) had carcinoembryonic antigen as a marker of his prostate cancer, which declined by 43\u00a0%. Toxicities regardless of relationship to panobinostat included fatigue (62.9\u00a0%), thrombocytopenia (45.7\u00a0%), nausea (51.4\u00a0%), and decreased appetite (37.1\u00a0%).\nCONCLUSIONS: Despite promising preclinical data and scientific rationale, treatment with IV panobinostat did not show a sufficient level of clinical activity to pursue further investigation as a single agent in CRPC.",
"genre": "research_article",
"id": "sg:pub.10.1007/s00280-013-2224-8",
"inLanguage": [
"en"
],
"isAccessibleForFree": true,
"isFundedItemOf": [
{
"id": "sg:grant.7143909",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.2438793",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.2438809",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.7144010",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1088364",
"issn": [
"0344-5704",
"1432-0843"
],
"name": "Cancer Chemotherapy and Pharmacology",
"type": "Periodical"
},
{
"issueNumber": "3",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "72"
}
],
"name": "A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer",
"pagination": "537-544",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"549d4c70e11fb3ae41733604c96ac5a1b4345496a8ab2666d7928e500b387e78"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"23820963"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"7806519"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s00280-013-2224-8"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1017758793"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s00280-013-2224-8",
"https://app.dimensions.ai/details/publication/pub.1017758793"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-10T19:57",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8681_00000511.jsonl",
"type": "ScholarlyArticle",
"url": "http://link.springer.com/10.1007%2Fs00280-013-2224-8"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00280-013-2224-8'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00280-013-2224-8'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00280-013-2224-8'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00280-013-2224-8'
This table displays all metadata directly associated to this object as RDF triples.
321 TRIPLES
21 PREDICATES
75 URIs
36 LITERALS
24 BLANK NODES